Evaluation of 6 cardiac troponin assays in patients with acute coronary syndrome

Saudi Medical Journal

Volumn 24, Issue 10, 2003, Pages 1092-1097

  Saadeddin, Salam M ^a   Habbab, Moh'd A ^b   Siddieg, Hisham H ^a   Al Seeni, Mohammed N ^a   Tahery, Ashraf B ^b   Sobki, Samia H ^a   Dafterdar, Rofaida ^a  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

^b PRINCE SULTAN CARDIAC CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN; TROPONIN I; TROPONIN T;

ANALYTICAL PARAMETERS; ARTICLE; BLOOD SAMPLING; CALCULATION; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EVALUATION; EVIDENCE BASED MEDICINE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PATIENT MONITORING; PERFORMANCE; PREDICTION; PROGNOSIS; PROTEIN DETERMINATION; PUBLIC HOSPITAL; QUALITY CONTROL; RELIABILITY; SAUDI ARABIA; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; TIME;

ADULT; AGED; CHEMILUMINESCENT MEASUREMENTS; CORONARY ARTERIOSCLEROSIS; EQUIPMENT FAILURE ANALYSIS; FEMALE; FLUOROIMMUNOASSAY; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TROPONIN I; TROPONIN T;

EID: 0242551949     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Zot AS, Potter JD. Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction. Annu Rev Biophys Biophys Chem 1987; 16: 535-539.
2. Leavis PC, Gergely J. Thin filament proteins and thin filament-linked regulation of vertebrate muscle contraction. CRC Crit Rev Biochem 1984; 16: 235-305.
3. Adams JE, Schechtman KB, Landt Y, Ladenson JH, Jaffe AS. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem 1994; 40: 1291-1295.
4. Katus HA, Remppis A, Neumann FJ, Scheffold T, Diederich KW, Vinar G et al. The diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991; 83: 902-912.
5. Potter JB. Preparation of troponin and its subunits. Methods Enzymol 1982; 85: 241-263.
6. Staprans J, Takahashi H, Russell MP, Watanabe S. Skeletal and cardiac troponins and their components. J Biochem (Tokyo) 1973; 72: 723-735.
7. Wade R, Kedes L. Developmental regulation of contractile protein genes. Annu Rev Physiol 1989; 51: 179-188.
8. Wilkinson JM, Grand RJA. Comparison of amino acid sequence of troponin I from different striated muscles. Nature 1978; 271: 31-35.
9. Gusev NB, Barskaya NV, Verin AD, Duzhenkova IV, Khuchua ZA, Zheltova AO. Some properties of cardiac troponin T structure. Biochem J 1983; 213: 123-129.
10. Mair J, Morandell D, Genser N, Lechleitner P, Dienstl F, Puschendorf B. Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction. Clin Chem 1995; 41: 1266-1272.
11. Storrow AB, Gibler WB. Chest pain centers: diagnosis of acute coronary syndromes. Ann Emerg Med 2000; 35: 449-461.
12. Keffer JH. Myocardial markers of injury evolution and insights. Am J Clin Pathol 1996; 105: 305-320.
13. Christenson RH, Azzazy HME. Biochemical markers of the acute coronary syndromes. Clin Chem 1998; 44: 1855-1864.
14. Newby LK, Christenson RH, Ohman EM, Armstrong PW, Thompson TD, Lee KL et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. Circulation 1998; 998: 1853-1859.
15. Olatidoye AB, Wu AHB, Feng YJ, Waters D. Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies. Am Heart J 1998; 81: 1405-1410.
16. Saadeddin SM, Habbab MA, Ferns GA. Cardiac markers for assessing the acute coronary syndromes. A focus on cardiac troponins. Saudi Med J 2000; 21: 228-237.
17. Hamm CW, Heechen C, Goldmann B, Vahanian A, Adgey J, Miguel CM et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl J Med 1999; 340: 1634-1639.
18. Heeschen C, Hamm CW, Goldmann B, Deu A, Langenbrink L, White HD et al. Troponin concentration for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. Lancet 1999; 354: 1757-1762.
19. Lindahl B, Venge P. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. J Am Coll Cardiol 1997; 29: 43-48.
20. Wu AHB, Feng YJ, Moore R, Apple FS, McPherson PH, Buechler KF et al. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem 1998; 44: 1198-1208.
21. Bodor GS, Porterfield D, Voss EM, Smith S, Apple FS. Cardiac troponin I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem 1995: 41: 1710-1715.
22. Braun SL, Baum H, Neumeier D, Vogt W. Troponin T and troponin I after coronary artery bypass grafting: Discordant results in patients with renal failure. Clin Chem 1996; 42: 781.
23. Heller C, Zehelein J, Remppis A, Kubler W, Katus HA. Cardiac troponin T in patients with renal failure. J Am Coll Cardiol 1997; 29: 234A.
24. Keffer JH. Myocardial markers of injury, evolution and insights. Am J Clin Pathol 1996; 105: 305-320.
25. Adams JE, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson JH et al. Cardiac troponin I, a marker with high specificity for cardiac injury. Circulation 1993; 88: 101-106.
26. Benoist JF, Cosson C, Mimoz O, Edouard A. Serum cardiac troponin I, creatine kinase (CK), and CK-MB inearly post traumatic rhabdomyolysis. Clin Chem 1997; 43: 416-417.
27. Braun SL, Pongratz DE, Bialk P, Liem S, Schlotter B, Vogt W. Discrepant results for cardiac troponin T and troponin I in chronic myopathy, depending on instrument and assay generation. Clin Chem 1996; 42: 2039.
28. Saadeddin SM, Habbab MA, Sobki SH, Ferns GA. Detection of minor myocardial injury after successful percutaneous transluminal coronary angioplasty with or without stenting. Med Sci Monit 2000; 6: 708-712.
29. Saadeddin SM, Habbab MA, Sobki SH, Ferns GA. Minor myocardial injury after lective uncomplicated successful PTCA with or without stenting: Detection by cardiac troponins. Catheter Cardiovasc Interv 2001; 53: 188-192.
30. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
31. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 244: 1874-1887.
32. FRISC II investigators. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomised multicentre study. Fragmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 1999; 345: 708-715.
33. Apple FS, Wu AHB, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 2002; 144: 981-986.